TipRanks

Notifications

3 Stocks to Buy Today, 2/6/2023, According to Top Analysts

Which stocks to buy today? According to top Wall Street analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating today and has a significant upside as well.

To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by top-ranking analysts.

Here are today’s stocks. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio.

Intra-Cellular Therapies (NASDAQ:ITCI) – Intra-Cellular is a biopharmaceutical company with three Buy ratings from top analysts. Today, analyst Graig Suvannavejh of Mizuho Securities reiterated his Buy rating on ITCI stock with a price target of $72. The consensus 12-month forecast of top analysts on the stock indicates a massive upside of 54.7%.

UBS Group AG (NYSE:UBS) – Six top analysts have recently given a Buy rating to UBS Stock. Switzerland-based UBS Group AG is a multinational investment bank and financial services company. Today, analyst Benjamin Goy of Deutsche Bank maintained his Buy rating on the stock with a price target of $25.90. Further, the consensus 12-month price target of top analysts is $26.61, suggesting an upside of 22.6%.

Altimmune (NASDAQ:ALTI) – All four top analysts recently rated ALT stock a Buy rating. Altimmune is a clinical-stage biopharmaceutical company focused on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. Today, analyst Jonathan Wolleben of JMP Securities reiterated a Buy rating on the stock with a price target of $26. The stock’s 12-month price prediction, based on the consensus of top analysts, implies an impressive upside of 68.21%.

Who are the Top Analysts?

TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. See real-time analyst rankings and learn more about the performance of top analysts on TipRanks’ Top Wall Street Analysts page.

Disclosure

Tags: , , ,
Sheryl Sheth
Sheryl Sheth has been a stock news and financial analysis writer at TipRanks since 2021. She covers a wide range of topics, including company stock analysis, market news reports, earnings analysis, crypto-related articles, social media posts, and informative content writing. As a professional financial writer, Sheryl writes on stocks primarily listed on the NYSE and the NASDAQ. Sheryl started her career as an equity research analyst for Guggenheim Transparent Value Pvt. Ltd. in 2007. Her primary focus was fundamental analysis, including DCF valuation of companies from the banking and finance sector. Hailing from a family of entrepreneurs, Sheryl also has the experience of owning and managing a printing company for six years, before joining TipRanks as a financial writer in May 2021. She holds an MBA degree with a specialization in Finance from Mumbai University. In her free time, Sheryl likes traveling and exploring new places, dancing to keep fit, and listening to music to unwind.